Skip to content
Pharma GXPGlobal Consulting

CQV Documentation & Validation Support

Apex-level CQV governance through to execution — Master Plans, risk assessments, and URS-through-PQ protocols for facilities, utilities, equipment, and computerized systems.

In short

CQV — Commissioning, Qualification and Validation — is the documented lifecycle that proves a pharmaceutical facility, utility, equipment item or computerized system is installed correctly, operates as specified, and performs as intended before it is released for GMP manufacturing use.

CQV work lives or dies on the documents underneath it. I’ve authored apex-level governance documents — CQV Master Plans, System Level Impact Assessments, and Quality Risk Assessments — and carried them through to URS, FAT, SAT, IQ, OQ, and PQ execution across facilities, black-and-clean utilities, process equipment, and computerized systems.

That work spans oral solid dose, oral liquid, injectable/sterile, biologics, and vaccine environments, delivered across India, Thailand, Vietnam, and the UK — including leading CQV execution at a government-owned pharmaceutical manufacturing site in Southeast Asia, commissioning and qualification of a sterile manufacturing facility in Newcastle, UK, and direct involvement in the international technology transfer of a Hepatitis-B r-DNA vaccine process from Cuba to India. I bring the same rigor to a single equipment qualification as to a full facility CQV Master Plan.

How CQV Documentation engagements work

  1. 1

    Design review & URS

    Translate user requirements into a validation-ready URS before design freezes.

  2. 2

    Risk & impact assessment

    SLIA and QRA to focus validation effort on what's actually GMP-critical.

  3. 3

    Protocol authoring

    FAT, SAT, IQ, OQ, and PQ protocols written for real execution, not just approval.

  4. 4

    Execution oversight

    On-site or remote oversight through execution, with deviations resolved as they happen, not weeks later.

  5. 5

    Validation summary & release

    A validation summary report that stands up to review and supports system release.

FAQ

CQV Documentation — frequently asked questions

What does CQV stand for in pharma?

CQV stands for Commissioning, Qualification and Validation. Commissioning is the engineering process of starting up a system and handing it over against its design intent. Qualification is the GMP-regulated documented verification — DQ, IQ, OQ and PQ — that the GMP-critical aspects of that system perform as intended. Validation extends the same logic to processes, cleaning and computerized systems across the product lifecycle.

What is the difference between commissioning and qualification?

Commissioning is an engineering activity: it confirms a system was built, installed and started up in line with the design and the supplier's specification. Qualification is a GMP activity: it provides documented, approved evidence that the aspects of that system which affect product quality perform as intended. Under a risk-based approach (ASTM E2500, ISPE Baseline Guide Vol. 5), sound commissioning evidence can be leveraged into qualification rather than repeated — provided the quality unit has approved that strategy in advance, in writing.

What is a CQV Master Plan (CQVMP)?

A CQV Master Plan is the apex governance document of a validation programme. It defines the scope and system boundaries, the organisation and responsibilities, the risk-assessment approach used to decide what gets qualified and to what depth, the document hierarchy from URS through to summary report, the acceptance and deviation-handling rules, and the criteria for system release. Every document beneath it — SLIA, QRA, URS, FAT, SAT, IQ/OQ/PQ and the RTM — inherits its logic from the CQVMP.

Which standards govern risk-based commissioning and qualification?

ASTM E2500 sets the risk- and science-based verification approach. The ISPE Baseline Guide Volume 5 (Commissioning and Qualification) is the practical implementation guide for it. EudraLex Vol. 4 Annex 15 sets EU expectations for qualification and validation, and GAMP 5 covers computerized systems. One point of frequent confusion: ISPE Volume 5 is the C&Q guide — Volume 4 is Water and Steam Systems, a different document entirely.

Do you author protocols only, or oversee execution as well?

Both. Protocols written without execution experience tend to fail on the floor — an OQ test that cannot physically be performed with the instrumentation actually installed is a deviation waiting to happen. Engagements typically run from design review and URS through protocol authoring to execution oversight, on-site or remote, with deviations resolved as they arise rather than at report stage.

Let’s talk

Ready to talk about CQV Documentation?

Share a little about your site and timeline — I'll follow up within one to two business days with next steps.